Grant: Discovery Grants Program - Individual
Université Laval
$40,000.00
Ectonucleotidases and Extracellular Nucleotides in Smooth Muscle Cell Contraction
EF 2024-25
Résumé
The research of my laboratory aims to elucidate the roles of extracellular nucleotide signaling and to define their mode of action in mammals. Nucleotides such as ATP and ADP are released in a regulated manner by cells such as smooth muscle cells (SMC) and nerves innervating SMC. Once outside the cell, nucleotides activate specific P2-receptors. The hydrolysis of ATP and ADP to adenosine by ectonucleotidases terminates the latter's effects and causes the activation of adenosine (P1) receptors which often results in different physiological effects to those elicited by P2-receptor activation. We have recently demonstrated that NTPDase1 was the dominant ectonucleotidase in the SMC of vas deferens and bladder, and that it was affecting smooth muscle (SM) contraction by regulating the activation of different nucleotide receptors. We therefore hypothesize that NTPDase1 is the major ectonucleotidase at the surface of non-vascular SMC in general, and that its activity affects contraction via the regulation of the P2 receptor agonist levels. The long-term objective of my NSERC research program is to elucidate the role and mechanisms of extracellular nucleotide signaling in non-vascular SM contraction and to develop tools to study ectonucleotidases' biology. To address this problem, we have designed the following objectives.
Obj 1: Determine whether non-vascular SMC express ectonucleotidase activity and identify the enzyme(s).
Obj 2: Evaluate the role of the ectonucleotidase(s) identified in SM contraction.
Obj 3: Identify the P2 receptors involved in the regulation of SM contraction.
Obj 4: Develop specific and potent inhibitors of ectonucleotidases to study their functions.
Obj 1 will be done by enzyme histochemistry of SM from the respiratory, reproductive and gastrointestinal tracts. The identity of the ectonucleotidase will be carried out by quantitative RT-PCR, immunohistochemistry and Western blot. Obj 2 will be done by the comparison of isometric contraction of WT tissues with tissues from mice deficient for the ectonucleotidase identified in Obj 1, and also by assessing calcium mobilization in primary SMC cultures under different stimuli including exogenous ATP and ADP. The identification of the P2 receptors involved in SM contraction observed in Obj 2 will be evaluated in Obj 3 with antagonists, SiRNAs and KO mice deficient for the P2 receptor candidates. In Obj 4 we will characterize the effects of molecules, designed and synthetized by our chemist collaborators, on the activity of recombinant ectonucleotidases.
In this work we expect to define a basic mechanism of non-vascular SM contraction involving extracellular nucleotide signaling. We will identify the ectonucleotidase and the P2 receptors involved in this biological process. In the mean time we will also determine whether the epithelia affects SM contraction. We will finally develop tools to study ectonucleotidases' functions that may also be used as potential therapeutic agents.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2023-05498
Name nom
Sévigny, Jean
Department département
Microbiologie-infectiologie et d'immunologie - Microbiologie-infectiologie et d'immunologie
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
40000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5500
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal biology
Research subject fr
Biologie animale
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Ectonucleotidases and Extracellular Nucleotides in Smooth Muscle Cell Contraction
Keywords
ntpdase1; smooth muscle cells; p2 receptors; atp; adp; utp; udp; contraction; ecto-nucleotidase; ecto-atpase
Application summary
The research of my laboratory aims to elucidate the roles of extracellular nucleotide signaling and to define their mode of action in mammals. Nucleotides such as ATP and ADP are released in a regulated manner by cells such as smooth muscle cells (SMC) and nerves innervating SMC. Once outside the cell, nucleotides activate specific P2-receptors. The hydrolysis of ATP and ADP to adenosine by ectonucleotidases terminates the latter's effects and causes the activation of adenosine (P1) receptors which often results in different physiological effects to those elicited by P2-receptor activation. We have recently demonstrated that NTPDase1 was the dominant ectonucleotidase in the SMC of vas deferens and bladder, and that it was affecting smooth muscle (SM) contraction by regulating the activation of different nucleotide receptors. We therefore hypothesize that NTPDase1 is the major ectonucleotidase at the surface of non-vascular SMC in general, and that its activity affects contraction via the regulation of the P2 receptor agonist levels. The long-term objective of my NSERC research program is to elucidate the role and mechanisms of extracellular nucleotide signaling in non-vascular SM contraction and to develop tools to study ectonucleotidases' biology. To address this problem, we have designed the following objectives.
Obj 1: Determine whether non-vascular SMC express ectonucleotidase activity and identify the enzyme(s).
Obj 2: Evaluate the role of the ectonucleotidase(s) identified in SM contraction.
Obj 3: Identify the P2 receptors involved in the regulation of SM contraction.
Obj 4: Develop specific and potent inhibitors of ectonucleotidases to study their functions.
Obj 1 will be done by enzyme histochemistry of SM from the respiratory, reproductive and gastrointestinal tracts. The identity of the ectonucleotidase will be carried out by quantitative RT-PCR, immunohistochemistry and Western blot. Obj 2 will be done by the comparison of isometric contraction of WT tissues with tissues from mice deficient for the ectonucleotidase identified in Obj 1, and also by assessing calcium mobilization in primary SMC cultures under different stimuli including exogenous ATP and ADP. The identification of the P2 receptors involved in SM contraction observed in Obj 2 will be evaluated in Obj 3 with antagonists, SiRNAs and KO mice deficient for the P2 receptor candidates. In Obj 4 we will characterize the effects of molecules, designed and synthetized by our chemist collaborators, on the activity of recombinant ectonucleotidases.
In this work we expect to define a basic mechanism of non-vascular SM contraction involving extracellular nucleotide signaling. We will identify the ectonucleotidase and the P2 receptors involved in this biological process. In the mean time we will also determine whether the epithelia affects SM contraction. We will finally develop tools to study ectonucleotidases' functions that may also be used as potential therapeutic agents.